Australia's MedAdvisor hits more than 2-month high on upbeat outlook

Adheris Health

27/11/2023 01:07

** Shares of Australia's MedAdvisor Ltd  MDR.AX  rise as
much as 17.1% to A$0.240
    ** Stock hits highest since and is set to mark best day
since Sept. 20, if current trend holds 
    ** Medication technology co says group revenue for 1H FY24
to increase by 10-15% from year ago period 
    ** Co re-iterates its guidance for profitable growth being
achieved in FY24           
    ** Stock has fallen 21.2% this year, as of last close

 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))